<?xml version="1.0" encoding="UTF-8"?><response><lst name="responseHeader"><int name="status">0</int><int name="QTime">1</int><lst name="params"><str name="sort">da desc</str><str name="tr">export-xml.xsl</str><str name="q">id:mdl-22296793</str><str name="facet.limit">20</str><str name="qt">standard</str><str name="wt">xslt</str><str name="rows">12</str></lst></lst><result name="response" numFound="1" start="0"><doc><arr name="ab"><str>BACKGROUND: Hawaii and the United States-affiliated Pacific islands (USAPI) host over 8 million travelers annually, most of whom originate in Asia, Australia, and the Americas where prevalence of oseltamivir resistance in 2009 pandemic influenza A (H1N1) has been reported to be 2.5-3.5%. OBJECTIVE: To survey a collection of samples from Hawaii and the USAPI that had tested positive for the 2009 pandemic influenza A (H1N1) virus by RTI-PCR to assess whether antiviral resistance emerged in these island communities during the 2009 H1N1 pandemic. STUDY DESIGN: We examined RNA extracted from Hawaiian and USAPI cases for the neuraminidase H275Y mutation associated with oseltamivir resistance by pyrosequencing. RESULTS: Two hundred and sixty-three (263) 2009 pandemic influenza A (H1N1) positive specimens were tested and 263/263 (100%) were shown to lack the mutation most commonly associated with oseltamivir resistance. CONCLUSIONS: There was no evidence of oseltamivir resistant A(H1N1)pdm09 virus during the 2009 pandemic in the Pacific islands despite considerable travel exposure. Geographic isolation, the lack of a "second wave" of pandemic influenza, judicious antiviral use, aggressive vaccination, and below average tourism due to the global economic crisis may have been contributing factors. Continued surveillance and vigilance is necessary to monitor unpredictable influenza activity.</str></arr><arr name="au"><str>Miller HB</str><str>Gose RB</str><str>Nagata MT</str><str>Sciulli RH</str><str>Whelen AC</str></arr><str name="bvs">h1n1</str><arr name="cp"><str>Netherlands</str></arr><str name="da">201204</str><arr name="db"><str>MEDLINE</str></arr><arr name="fo"><str>J Clin Virol;54(1): 73-5, 2012 May. </str></arr><str name="id">mdl-22296793</str><arr name="ip"><str>1</str></arr><arr name="la"><str>en</str></arr><arr name="mh"><str>Antivirais/farmacologia</str><str>Farmacorresistência Viral</str><str>Vírus da Influenza A Subtipo H1N1/efeitos de drogas</str><str>Influenza Humana/epidemiologia</str><str>Influenza Humana/virologia</str><str>Oseltamivir/farmacologia</str><str>Substituição de Aminoácidos</str><str>Hawaii/epidemiologia</str><str>Humanos</str><str>Vírus da Influenza A Subtipo H1N1/isolamento &amp; purificação</str><str>Testes de Sensibilidade Microbiana/métodos</str><str>Proteínas Mutantes/genética</str><str>Mutação de Sentido Incorreto</str><str>Neuraminidase/genética</str><str>Ilhas do Pacífico/epidemiologia</str><str>Prevalência</str><str>RNA Viral/genética</str><str>Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos</str><str>Proteínas Virais/genética</str></arr><arr name="pg"><str>73-5</str></arr><arr name="pt"><str>Artigo de Revista</str><str>Research Support, Non-U.S. Gov&apos;t</str></arr><arr name="ta"><str>J Clin Virol</str></arr><arr name="ti"><str>Pacific region influenza surveillance for oseltamivir resistance.</str></arr><arr name="type"><str>article</str></arr><arr name="ur"><str>http://dx.doi.org/10.1016/j.jcv.2012.01.007</str></arr><arr name="vi"><str>54</str></arr></doc></result><lst name="facet_counts"><lst name="facet_queries"/><lst name="facet_fields"><lst name="type"><int name="article">1</int></lst><lst name="tag"><int name="epidemiologia">1</int><int name="geral">1</int><int name="tratamento">1</int><int name="virologia">1</int></lst><lst name="fulltext"><int name="1">1</int></lst><lst name="mh_cluster"><int name="Antivirais">1</int><int name="Farmacorresistência Viral">1</int><int name="Influenza Humana">1</int><int name="Vírus da Influenza A Subtipo H1N1">1</int><int name="Oseltamivir">1</int></lst><lst name="limit"/><lst name="ta_cluster"><int name="J Clin Virol">1</int></lst><lst name="la"><int name="en">1</int></lst><lst name="year_cluster"><int name="2012">1</int></lst></lst><lst name="facet_dates"/><lst name="facet_ranges"/></lst></response>